未经评估:全球,COVID-19大流行对心理健康有重大影响。在尼泊尔,COVID-19阳性病例必须在多代和多户家庭的家中自我隔离。这可能与抑郁症密切相关,焦虑,和压力相关的健康结果。此外,与COVID-19相关的污名和对传播的恐惧可能会加剧抑郁症,焦虑,和压力症状。这项研究确定了抑郁症的患病率,焦虑,在卡纳利省家庭隔离的COVID-19阳性患者中,压力症状及其与COVID-19症状和合并症的关系,尼泊尔。
未经评估:我们进行了一项横断面研究来评估抑郁症,焦虑,2021年1月至5月,卡纳利省402名家庭隔离的COVID-19患者出现压力症状,使用“抑郁症”,焦虑和压力量表-21(DASS-21)\“。我们采访了患者以收集社会人口统计信息,DASS-21,COVID-19症状,合并症条件,自我治疗。我们使用Kobotoolbox使用标准化问卷进行了电话访谈。我们计算了抑郁症的患病率,焦虑,和压力症状。我们利用单变量和多变量逻辑回归来确定它们与COVID-19症状和合并症的存在的关联。在多变量逻辑回归中,我们调整了社会人口因素(年龄,性别,种族,婚姻状况,家庭月收入,教育水平),吸烟状况和自我治疗史。我们报告了具有95%置信区间的调整比值比(aOR)。所有分析均在R(版本:4.0.3)中进行。
未经证实:抑郁症的患病率,家庭隔离的COVID-19患者的焦虑和压力症状为8.0%(95%CI:5.5至11.1),11.2%(95%CI:8.3至14.7),和4.0%(95%CI:2.3至6.4)。出现抑郁症状的几率更高(aOR:2.86;95%CI:1.10-7.44,p=0.03),焦虑症状(aOR:3.81;95%CI:1.62至8.93;p=<0.01)和应激症状(aOR:7.78;95%CI:1.43至42.28;p=0.02)与过去一周的COVID-19症状存在显着相关。较高的焦虑症状几率与合并症的存在有关(aOR=2.92;95%CI:1.09至7.80;p=0.03)。
未经证实:抑郁症,焦虑,在尼泊尔西部,很大一部分家庭隔离的COVID-19患者存在压力症状,并且与COVID-19症状的存在呈正相关。在这场全球COVID-19大流行中,重要的是要及时向有合并症和COVID-19症状的高危人群提供咨询,以维持家庭隔离的COVID-19患者的高水平心理健康。
UNASSIGNED: Globally, COVID-19 pandemic has a significant impact on mental health. In Nepal, COVID-19 positive cases have to self-isolate at home in multi-generational and multi-family households. This could be strongly associated with depression, anxiety, and stress-related health outcomes. Additionally, COVID-19 related stigma and fear of transmission may intensify depression, anxiety, and stress symptoms. This study determined the prevalence of depression, anxiety, and stress symptoms and their association with presence of COVID-19 symptoms and comorbid conditions among home isolated COVID-19 positives in the Karnali province, Nepal.
UNASSIGNED: We conducted a cross-sectional study to assess depression, anxiety, and stress symptoms among 402 home isolated COVID-19 patients of Karnali province from January to May 2021 using \"Depression, Anxiety and Stress Scale-21 (DASS-21)\". We interviewed patients to collect socio-demographic, DASS-21, COVID-19 symptoms, comorbid conditions, and self-treatment. We conducted a telephonic interview using a standardized questionnaire using Kobotoolbox. We calculated the prevalence of depression, anxiety, and stress symptoms. We utilized univariate and multivariate logistic regression to determine their association with the presence of COVID-19 symptoms and comorbid conditions. In multivariate logistic regression, we adjusted sociodemographic factors (age, gender, ethnicity, marital status, monthly family income, education level), smoking status and history of self-treatment. We reported adjusted odds ratios (aOR) with 95% confidence intervals. All analyses were conducted in R (version: 4.0.3).
UNASSIGNED: The prevalence of depression, anxiety and stress symptoms among home isolated COVID-19 patients were 8.0% (95% CI: 5.5 to 11.1), 11.2% (95% CI: 8.3 to 14.7), and 4.0% (95% CI: 2.3 to 6.4) respectively. Higher odds of depression symptoms (aOR: 2.86; 95% CI: 1.10-7.44, p = 0.03), anxiety symptoms (aOR: 3.81; 95% CI: 1.62 to 8.93; p = <0.01) and stress symptoms (aOR: 7.78; 95% CI: 1.43 to 42.28; p = 0.02) were associated significantly with presence of COVID-19 symptoms in past week. Higher odds of anxiety symptoms were associated with the presence of comorbid conditions (aOR = 2.92; 95% CI: 1.09 to 7.80; p = 0.03).
UNASSIGNED: Depression, anxiety, and stress symptoms were present in a significant proportion of home isolated COVID-19 patients in western Nepal and positively associated with the presence of COVID-19 symptoms. In this global COVID-19 pandemic, it is important to provide timely counseling to high-risk groups like those with comorbidities and COVID-19 symptoms to maintain a high level of mental health among home isolated COVID-19 patients.